The F.T.C. and H.H.S. are examining the tactics of group purchasing organizations that generic industry executives say have led to scarce supplies of treatments like chemotherapy.
Author: Christina Jewett
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}